File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: Telbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study
  • Basic View
  • Metadata View
  • XML View
TitleTelbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study
 
AuthorsThongsawat, S
Lai, CL
Gane, E
Chao, G
Fielman, B
Brown, N
GLOBE Investigator Group, .
 
Issue Date2006
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
CitationJournal of Hepatology, v. 44 n. Suppl 2, p. S49 [How to Cite?]
 
ISSN0168-8278
2012 Impact Factor: 9.858
2012 SCImago Journal Rankings: 2.797
 
DC FieldValue
dc.contributor.authorThongsawat, S
 
dc.contributor.authorLai, CL
 
dc.contributor.authorGane, E
 
dc.contributor.authorChao, G
 
dc.contributor.authorFielman, B
 
dc.contributor.authorBrown, N
 
dc.contributor.authorGLOBE Investigator Group, .
 
dc.date.accessioned2010-09-25T19:31:45Z
 
dc.date.available2010-09-25T19:31:45Z
 
dc.date.issued2006
 
dc.identifier.citationJournal of Hepatology, v. 44 n. Suppl 2, p. S49 [How to Cite?]
 
dc.identifier.hkuros122315
 
dc.identifier.issn0168-8278
2012 Impact Factor: 9.858
2012 SCImago Journal Rankings: 2.797
 
dc.identifier.issueSuppl 2
 
dc.identifier.openurl
 
dc.identifier.spage49
 
dc.identifier.urihttp://hdl.handle.net/10722/100995
 
dc.identifier.volume, v. 44 n. Suppl 2
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
dc.relation.ispartofJournal of Hepatology
 
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
 
dc.titleTelbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Thongsawat, S</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<contributor.author>Gane, E</contributor.author>
<contributor.author>Chao, G</contributor.author>
<contributor.author>Fielman, B</contributor.author>
<contributor.author>Brown, N</contributor.author>
<contributor.author>GLOBE Investigator Group, .</contributor.author>
<date.accessioned>2010-09-25T19:31:45Z</date.accessioned>
<date.available>2010-09-25T19:31:45Z</date.available>
<date.issued>2006</date.issued>
<identifier.citation>Journal of Hepatology, v. 44  n. Suppl 2, p. S49</identifier.citation>
<identifier.issn>0168-8278</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/100995</identifier.uri>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/jhep</publisher>
<relation.ispartof>Journal of Hepatology</relation.ispartof>
<rights>Journal of Hepatology. Copyright &#169; Elsevier BV.</rights>
<title>Telbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0168-8278&amp;volume=44 &amp;issue=Suppl 2&amp;spage=S49&amp;epage=&amp;date=2006&amp;atitle=Telbivudine+displays+consistent+antiviral+efficacy+across+patient+subgroups+for+the+treatment+of+chronic+hepatitis+B:+Results+from+the+GLOBE+study</identifier.openurl>
<identifier.hkuros>122315</identifier.hkuros>
<identifier.volume>, v. 44  n. Suppl 2</identifier.volume>
<identifier.issue>Suppl 2</identifier.issue>
<identifier.spage>49</identifier.spage>
</item>